Pelvic Lymph Node Dissection in Prostate Cancer does not affect the risk of biochemical failure after radical prostatectomy. BJU Int 2010;105:176-9. 76. Weight CJ, Reuther AM, Gunn PW, Zippe CR, Dhar NB, Klein EA. Limited pelvic lymph node dissection does not improve bio- chemical relapse-free survival at 10 years after radical prostatec- tomy in patients with low-risk prostate cancer. Urology 2008;71: 141-5. 77. Berglund RK, Sadetsky N, DuChane J, Carroll PR, Klein EA. Limited pelvic lymph node dissection at the time of radical prosta- tectomy does not affect 5-year failure rates for low, intermediate 445 and high risk prostate cancer: results from CaPSURE. J Urol 2007;177:526-29. 78. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, et al. EAU guidelines on prostate cancer. Eur Urol 2008;53: 68-80. 79. Kröpfl D, Krause R, Hartung R, Pfeiffer R, Behrendt H. Subcutaneous heparin injection in the upper arm as a method of avoiding lymphoceles after lymphadenectomies in the lower part of the body. Urol Int 1987;42:416-23. Korean J Urol 2011;52:437-445